Get started
Author

Flavia D’Alessio

Observed names: Flavia D'Alessio, Flavia Dalessio, Flavia d'Alessio
ORCID: 0000-0002-0349-7302
Observed ORCID: 0000-0002-0349-7302
OpenAlex ID: A5076537677
The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation
2012 · Flavia D’Alessio, Matthias W. Hentze, et al. · Journal of Hepatology · 212
Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model
2017 · Hazel C. Dobinson, Malick M. Gibani, et al. · Clinical Infectious Diseases · 85
PDF
Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling
2014 · Katarzyna Mleczko-Sanecka, Franziska Roche, et al. · Blood · 74
A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA
2010 · Sandro Altamura, Flavia D'Alessio, et al. · Biochemical Journal · 47
PDF
Clinical development of placental malaria vaccines and immunoassays harmonization: a workshop report
2016 · Arnaud Chêne, Sophie Houard, et al. · Malaria Journal · 46
PDF
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial
2017 · Victorine A. Mensah, Sophie Roetynck, et al. · Frontiers in Immunology · 28
PDF
A Multi-Scale Model of Hepcidin Promoter Regulation Reveals Factors Controlling Systemic Iron Homeostasis
2014 · Guillem Casanovas, Anashua Banerji, et al. · PLoS Computational Biology · 28
PDF
Workshop report: Immunoassay standardisation for “universal” influenza vaccines
2017 · Sophia Pavlova, Flavia D'Alessio, et al. · Influenza and Other Respiratory Viruses · 17
PDF
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial
2023 · Alphonse Ouédraogo, Edith Christiane Bougouma, et al. · Frontiers in Immunology · 11
PDF
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children
2022 · Edith Christiane Bougouma, Nirianne Marie Q. Palacpac, et al. · Frontiers in Immunology · 9
PDF
Workshop report: Experimental animal models for universal influenza vaccines
2018 · Flavia D'Alessio, Gerrit Koopman, et al. · Vaccine · 9
Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children
2023 · Alfred B. Tiono, Nirianne Marie Q. Palacpac, et al. · Frontiers in Immunology · 8
PDF
Placental malaria: a systematic review and meta-analysis of global burden, risk factors, and maternal and foetal outcomes
2025 · Sonia Menon, Flavia D’Alessio, et al. · Journal of Global Health · 6
PDF
Workshop report: Malaria vaccine development in Europe–preparing for the future
2015 · Nicola K. Viebig, Flavia D’Alessio, et al. · Vaccine · 5
Systemic inflammatory markers of visceral leishmaniasis treatment response in East Africa
2026 · Ayenew Addisu, Alice Bayiyana, et al. · PLoS neglected tropical diseases · 3
PDF
Safety, Tolerability, and Immunogenicity of the InvaplexAR-Detox Shigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial
2025 · Geert V. T. Roozen, Nsofwa Sukwa, et al. · Vaccines · 3
PDF
African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination
2022 · Nobuko Arisue, Nirianne Marie Q. Palacpac, et al. · Frontiers in Cellular and Infection Microbiology · 2
PDF
Modelling the Cost-Effectiveness of a Placental Malaria Vaccine in Sub-Saharan Africa
2026 · Jobiba Chinkhumba, Lucinda Manda-Taylor, et al. · Vaccines · 1
PDF
Immunization strategies to prevent malaria in pregnancy – a multistakeholder workshop
2026 · Flavia D'Alessio, Josiane Honkpehedji, et al. · Vaccine · 1
Plasma proteomic profiling identifies country-specific diversity in visceral leishmaniasis patients across East Africa
2026 · Joao Cunha, Ayenew Addisu, et al. · medRxiv
PDF
Assessing Readiness for Future Maternal Malaria Vaccines: Knowledge, Practices, and Vaccine Attitudes Among Women of Reproductive Age in Malawi
2026 · Mandeep Kaur, Flavia D’Alessio, et al. · Vaccines
PDF
Advancing Vaccine Strategies for Combatting Placental Malaria: A Path to Effective Implementation
2024 · Flavia Dalessio, Mandeep Kaur, et al. · International Journal of Biomedical and Clinical Analysis
PDF
Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5–10-Year-Old Burkinabe Children Naturally Exposed to Malaria
2024 · Issa Nebie, Nirianne Marie Q. Palacpac, et al. · Vaccines
PDF
PA-435 Long-term immune response in children vaccinated with BK-SE36/CpG blood stage malaria candidate vaccine in a malaria hyperendemic and seasonal area of Burkina Faso
2023 · Issa Nébié Ouedraogo, Nirianne Marie Q Palacpac, et al. · BMJ Global Health
PDF
PA-463 Phase 1b randomized, controlled, double-blinded, age de-escalation trial to evaluate the safety, reactogenicity and immunogenicity of BK-SE36/CpG malaria vaccine in Burkinabe healthy adults and children
2023 · Alphonse Ouedraogo, Edith Christiane Bougouma, et al. · BMJ Global Health
PDF
Works count: 28
Citation count: 595
H-index: 9
I10-index: 9
Year
Topic
Type